JENNIFER KIRLANGITIS: Open Payments
NPI 1992459937 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$151 in 7 payments from 6 companies in 2025. Trend: 2023 $48 · 2024 $202 · 2025 $151
Food & beverage: $151
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| PFIZER INC. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: REPATHA, JARDIANCE, VERQUVO, ONPATTRO, ELIQUIS, CAMZYOS.
Industry payments across FL — which companies pay providers there.
